Cargando…

Dihydroartemisinin inhibits IL-6-induced epithelial–mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway

OBJECTIVE: To explore whether dihydroartemisinin (DHA) can block interleukin (IL)-6-induced epithelial–mesenchymal transition (EMT) in laryngeal squamous cell carcinoma (LSCC). METHODS: The expression of SLUG, signal transducer and activator of transcription 3 (STAT3), and microRNA (miR)-130b-3p was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yajing, Lu, Xiuying, Li, Hui, Li, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Pre-Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586195/ https://www.ncbi.nlm.nih.gov/pubmed/34755560 http://dx.doi.org/10.1177/03000605211009494

Ejemplares similares

Correlation of signal transducer and activator of transcription-3 and β-catenin expression in laryngeal squamous cell carcinoma
por: Sun, Yajing, et al.
Publicado: (2023)

Dihydroartemisinin Prevents Distant Metastasis of Laryngeal Carcinoma by Inactivating STAT3 in Cancer Stem Cells
por: Wang, Weiyi, et al.
Publicado: (2020)

Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling
por: Jia, Lifeng, et al.
Publicado: (2016)

Dihydroartemisinin Prevents Progression and Metastasis of Head and Neck Squamous Cell Carcinoma by Inhibiting Polarization of Macrophages in Tumor Microenvironment
por: Chen, Ran, et al.
Publicado: (2020)

RalB degradation by dihydroartemisinin induces autophagy and IFI16/caspase-1 inflammasome depression in the human laryngeal squamous cell carcinoma
por: Shi, Xinli, et al.
Publicado: (2020)

Eupalinilide B as a novel anti-cancer agent that inhibits proliferation and epithelial–mesenchymal transition in laryngeal cancer cells
por: Jiang, Linlin, et al.
Publicado: (2022)

Effect of CADM1 on TPF-induced chemotherapy in laryngeal squamous cell carcinoma
por: Nie, Jiani, et al.
Publicado: (2023)

STAT3 regulates hypoxia-induced epithelial mesenchymal transition in oesophageal squamous cell cancer
por: CUI, YAO, et al.
Publicado: (2016)

Loss of Claudin-3 Expression Induces IL6/gp130/Stat3 Signaling to Promote Colon Cancer Malignancy by Hyperactivating Wnt/β-Catenin signaling
por: Ahmad, Rizwan, et al.
Publicado: (2017)

Epithelial-to-Mesenchymal Transition and Neoangiogenesis in Laryngeal Squamous Cell Carcinoma
por: Franz, Leonardo, et al.
Publicado: (2021)

Identification of prognostic immune genes in laryngeal cancer
por: Xiao, Huan, et al.
Publicado: (2020)

Effect of KLF17 overexpression on epithelial–mesenchymal transition of gastric cancer cells
por: Li, Shaoyi, et al.
Publicado: (2021)

Nelfinavir restricts A549 cell growth by inhibiting STAT3 signaling
por: He, Fangli, et al.
Publicado: (2021)

Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells
por: Li, Yachun, et al.
Publicado: (2020)

Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma
por: Zhu, Guang-Jie, et al.
Publicado: (2018)

STAT3 and epithelial–mesenchymal transitions in carcinomas
por: Wendt, Michael K, et al.
Publicado: (2014)

L'Europe aura en 1958 son laboratoire "atomique" pour 6 milliards. Il sera édifié á Geneve
Publicado: (1951)

Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the β-catenin/WISP1 signaling pathway
por: Yang, Canlin, et al.
Publicado: (2021)

Epithelial–mesenchymal transition and metastasis of colon cancer cells induced by the FAK pathway in cancer-associated fibroblasts
por: Xuefeng, Xuefeng, et al.
Publicado: (2020)

Fibrinogen like protein-1 knockdown suppresses the proliferation and metastasis of TU-686 cells and sensitizes laryngeal cancer to LAG-3 blockade
por: Huang, Jiameng, et al.
Publicado: (2022)

The cadherin–catenin complex in laryngeal squamous cell carcinoma
por: Galera-Ruiz, H., et al.
Publicado: (2011)

Pepsin promotes IL-8 signaling-induced epithelial–mesenchymal transition in laryngeal carcinoma
por: Tan, Jia-Jie, et al.
Publicado: (2019)

Yangxin granules alleviate doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis mediated by AKT/GSK3β/β-catenin signaling
por: Ren, Dezhi, et al.
Publicado: (2020)

ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway
por: Qu, Yi, et al.
Publicado: (2020)

Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin
por: Yang, Faying, et al.
Publicado: (2020)

STAT3 Signalling via the IL-6ST/gp130 Cytokine Receptor Promotes Epithelial Integrity and Intestinal Barrier Function during DSS-Induced Colitis
por: Pang, Lokman, et al.
Publicado: (2021)

A novel anti-lung cancer agent inhibits proliferation and epithelial–mesenchymal transition
por: Zhao, Wen, et al.
Publicado: (2022)

Effects of naringin on reversing cisplatin resistance and the Wnt/β-catenin pathway in human ovarian cancer SKOV3/CDDP cells
por: Zhu, Hong, et al.
Publicado: (2020)

LncRNA FOXP4-AS1 silencing inhibits metastasis and epithelial–mesenchymal transition in nasopharyngeal carcinoma via miR-136-5p/MAPK1
por: Yan, Jin, et al.
Publicado: (2023)

Marrow-derived mesenchymal stem cells regulate the inflammatory response and repair alveolar type II epithelial cells in acute lung injury of rats
por: Li, Qianying, et al.
Publicado: (2020)

SH2B3, Transcribed by STAT1, Promotes Glioblastoma Progression Through Transducing IL-6/gp130 Signaling to Activate STAT3 Signaling
por: Cai, Shan, et al.
Publicado: (2021)

Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway
por: Wu, Shibo, et al.
Publicado: (2020)

Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS–STAT3 pathway
por: Chen, Di, et al.
Publicado: (2022)

Dihydroartemisinin attenuates pulmonary inflammation and fibrosis in rats by suppressing JAK2/STAT3 signaling
por: You, Xiaolan, et al.
Publicado: (2022)

miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition
por: Wu, Yongyan, et al.
Publicado: (2021)

Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling
por: Pozios, Ioannis, et al.
Publicado: (2020)

Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signalling
por: Wang, Jiaqi, et al.
Publicado: (2020)

RHOJ Induces Epithelial-to-Mesenchymal Transition by IL-6/STAT3 to Promote Invasion and Metastasis in Gastric Cancer
por: Ma, Zhijie, et al.
Publicado: (2023)

Saturated hydrogen alleviates CCl(4)-induced acute kidney injury via JAK2/STAT3/p65 signaling
por: Wu, Song, et al.
Publicado: (2020)

GOLPH3 induces epithelial–mesenchymal transition via Wnt/β‐catenin signaling pathway in epithelial ovarian cancer
por: Sun, Jing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6h9e92mljeq84ipduesic5pbs8